ArticleInternational journal of molecular sciences2023

An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC.

Yanping Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.